Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Mayne Pharma Group Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

24 Sep 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Mayne Pharma Group Ltd (MYX-AU)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

29 Sep 2016 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Mayne Pharma Group Limited

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

28 Sep 2016 Wright Reports 64 $75.00

"The Economy Matters" Report for MAYNF: the economy's impact on MAYNF's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

27 Sep 2016 MacroRisk Analytics/EconomicInvestor 8 $25.00

Company Snapshot - Mayne Pharma Group Limited

A director at Mayne Pharma Group Limited sold 1,330,000 shares at 2.000AUD and the significance rating of the trade was 72/10...

23 Sep 2016 Directors Deals Ltd. 1 $12.00

Mayne Pharma Group Limited (MYX) - Financial Analysis Review

Mayne Pharma Group Limited (MYX) - Financial Analysis Review Summary Mayne Pharma Group Limited (Mayne Pharma) is a pharmaceu...

13 Sep 2016 GlobalData 64 $300.00

Is Mayne Pharma Group Ltd Worth its Desired Premium?

30 Aug 2016 Sadif Analytics Prime 12 $25.00

Mayne Pharma Group Ltd: Upgraded to Below Average

05 Aug 2016 Sadif Analytics Prime 3 $10.00

Mayne Pharma Group Limited (MYX) - Financial Analysis Review

Mayne Pharma Group Limited (MYX) - Financial Analysis Review Summary Mayne Pharma Group Limited (Mayne Pharma) is a pharmaceu...

16 Jun 2016 GlobalData 59 $300.00

Is Mayne Pharma Group Ltd Worth a Higher Bid?

31 May 2016 Sadif Analytics Prime 12 $25.00